In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease

Huntington's disease (HD) is characterized by numerous alterations within the corticostriatal circuitry. The striatum is innervated by a dense array of dopaminergic (DA) terminals and these DA synapses are critical to the proper execution of motor functions. As motor disturbances are prevalent...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in systems neuroscience 2011-01, Vol.5, p.61-61
Main Authors: Callahan, Joshua W, Abercrombie, Elizabeth D
Format: Article
Language:English
Subjects:
Basal Ganglia
Microdialysis
Neostriatum
neurodegeneration
Neuroscience
Substantia Nigra
transgenic
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c527t-f1178e362f6bfbe5fb752533889c350d3daea26d2ec9a6c6ab39552c1c5135fd3
cites
container_end_page 61
container_issue
container_start_page 61
container_title Frontiers in systems neuroscience
container_volume 5
creator Callahan, Joshua W
Abercrombie, Elizabeth D
description Huntington's disease (HD) is characterized by numerous alterations within the corticostriatal circuitry. The striatum is innervated by a dense array of dopaminergic (DA) terminals and these DA synapses are critical to the proper execution of motor functions. As motor disturbances are prevalent in HD we examined DA neurotransmission in the striatum in transgenic (tg) murine models of HD. We used in vivo microdialysis to compare extracellular concentrations of striatal DA in both a fragment (R6/2) model, which displays a rapid and severe phenotype, and a full-length (YAC128) model that expresses a more progressive phenotype. Extracellular striatal DA concentrations were significantly reduced in R6/2 mice and decreased concomitantly with age-dependent increasing motor impairments on the rotarod task (7, 9, and 11 weeks). In a sample of 11-week-old R6/2 mice, we also measured tissue concentrations of striatal DA and found that total levels of DA were significantly depleted. However, the loss of total DA content (
doi_str_mv 10.3389/fnsys.2011.00061
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_572d022e6e7c4147b9588ec6991230d1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_572d022e6e7c4147b9588ec6991230d1</doaj_id><sourcerecordid>881085362</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-f1178e362f6bfbe5fb752533889c350d3daea26d2ec9a6c6ab39552c1c5135fd3</originalsourceid><addsrcrecordid>eNpVks1u1DAUhSMEoqWwZ4W8a7vI1D-xk2yQqmmHjjQICcqCleXY11NXiT3YyYg-Bm-MZ6ZU7ca2fM_9rn10iuIjwTPGmvbC-vSQZhQTMsMYC_KqOCZC0JITVr9-dj4q3qV0nxVU8PZtcURJQ0hViePi79KjrdsGdBU2anAe0LW1_fQHuYSuQEdQCQxyHv0Yo1PjNKBgURfGO7SIaj2AH9HZd3FBz5HyBi2mvi9X4Ne5fvbrck5oc45uo_JpDd5p9DVMCfJqoE870M3kR5fVwZ_mcS7tpr0v3ljVJ_jwuJ8UPxfXt_ObcvXty3J-uSo1p_VYWkLqBpigVnS2A267mlOeXWlazTg2zChQVBgKulVCC9WxlnOqic6GcGvYSbE8cE1Q93IT3aDigwzKyf1FiGup4uh0D5LX1GBKQUCtK1LVXcubBrRoW0IZNiSzPh9Ym6kbwOhsS1T9C-jLind3ch22khHWtlWVAaePgBh-T5BGObikoe-Vh-yZbBqCG55_m5X4oNQxpBTBPk0hWO5CIfehkLtQyH0ocsun5697avifAvYPz7izUQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>881085362</pqid></control><display><type>article</type><title>In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease</title><source>PubMed Central</source><creator>Callahan, Joshua W ; Abercrombie, Elizabeth D</creator><creatorcontrib>Callahan, Joshua W ; Abercrombie, Elizabeth D</creatorcontrib><description>Huntington's disease (HD) is characterized by numerous alterations within the corticostriatal circuitry. The striatum is innervated by a dense array of dopaminergic (DA) terminals and these DA synapses are critical to the proper execution of motor functions. As motor disturbances are prevalent in HD we examined DA neurotransmission in the striatum in transgenic (tg) murine models of HD. We used in vivo microdialysis to compare extracellular concentrations of striatal DA in both a fragment (R6/2) model, which displays a rapid and severe phenotype, and a full-length (YAC128) model that expresses a more progressive phenotype. Extracellular striatal DA concentrations were significantly reduced in R6/2 mice and decreased concomitantly with age-dependent increasing motor impairments on the rotarod task (7, 9, and 11 weeks). In a sample of 11-week-old R6/2 mice, we also measured tissue concentrations of striatal DA and found that total levels of DA were significantly depleted. However, the loss of total DA content (&lt;50%) was insufficient to account for the full extent of DA depletion in the extracellular fluid (ECF; ∼75%). We also observed a significant reduction in extracellular DA concentrations in the striatum of 7-month-old YAC128 mice. In a separate set of experiments, we applied d-amphetamine (AMPH; 10 μm) locally into the striatum to stimulate the release of intracellular DA into the ECF. The AMPH-induced increase in extracellular DA levels was significantly blunted in 9-week-old R6/2 mice. There also was a decrease in AMPH-stimulated DA efflux in 7-month-old YAC128 mice in comparison to WT controls, although the effect was milder. In the same cohort of 7-month-old YAC128 mice we observed a significant reduction in the total locomotor activity in response to systemic AMPH (2 mg/kg). Our data demonstrate that extracellular DA release is attenuated in both a fragment and full-length tg mouse model of HD and support the concept of DA involvement in aspects of the syndrome.</description><identifier>ISSN: 1662-5137</identifier><identifier>EISSN: 1662-5137</identifier><identifier>DOI: 10.3389/fnsys.2011.00061</identifier><identifier>PMID: 21811446</identifier><language>eng</language><publisher>Switzerland: Frontiers Research Foundation</publisher><subject>Basal Ganglia ; Microdialysis ; Neostriatum ; neurodegeneration ; Neuroscience ; Substantia Nigra ; transgenic</subject><ispartof>Frontiers in systems neuroscience, 2011-01, Vol.5, p.61-61</ispartof><rights>Copyright © 2011 Callahan and Abercrombie. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-f1178e362f6bfbe5fb752533889c350d3daea26d2ec9a6c6ab39552c1c5135fd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139944/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139944/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21811446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Callahan, Joshua W</creatorcontrib><creatorcontrib>Abercrombie, Elizabeth D</creatorcontrib><title>In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease</title><title>Frontiers in systems neuroscience</title><addtitle>Front Syst Neurosci</addtitle><description>Huntington's disease (HD) is characterized by numerous alterations within the corticostriatal circuitry. The striatum is innervated by a dense array of dopaminergic (DA) terminals and these DA synapses are critical to the proper execution of motor functions. As motor disturbances are prevalent in HD we examined DA neurotransmission in the striatum in transgenic (tg) murine models of HD. We used in vivo microdialysis to compare extracellular concentrations of striatal DA in both a fragment (R6/2) model, which displays a rapid and severe phenotype, and a full-length (YAC128) model that expresses a more progressive phenotype. Extracellular striatal DA concentrations were significantly reduced in R6/2 mice and decreased concomitantly with age-dependent increasing motor impairments on the rotarod task (7, 9, and 11 weeks). In a sample of 11-week-old R6/2 mice, we also measured tissue concentrations of striatal DA and found that total levels of DA were significantly depleted. However, the loss of total DA content (&lt;50%) was insufficient to account for the full extent of DA depletion in the extracellular fluid (ECF; ∼75%). We also observed a significant reduction in extracellular DA concentrations in the striatum of 7-month-old YAC128 mice. In a separate set of experiments, we applied d-amphetamine (AMPH; 10 μm) locally into the striatum to stimulate the release of intracellular DA into the ECF. The AMPH-induced increase in extracellular DA levels was significantly blunted in 9-week-old R6/2 mice. There also was a decrease in AMPH-stimulated DA efflux in 7-month-old YAC128 mice in comparison to WT controls, although the effect was milder. In the same cohort of 7-month-old YAC128 mice we observed a significant reduction in the total locomotor activity in response to systemic AMPH (2 mg/kg). Our data demonstrate that extracellular DA release is attenuated in both a fragment and full-length tg mouse model of HD and support the concept of DA involvement in aspects of the syndrome.</description><subject>Basal Ganglia</subject><subject>Microdialysis</subject><subject>Neostriatum</subject><subject>neurodegeneration</subject><subject>Neuroscience</subject><subject>Substantia Nigra</subject><subject>transgenic</subject><issn>1662-5137</issn><issn>1662-5137</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVks1u1DAUhSMEoqWwZ4W8a7vI1D-xk2yQqmmHjjQICcqCleXY11NXiT3YyYg-Bm-MZ6ZU7ca2fM_9rn10iuIjwTPGmvbC-vSQZhQTMsMYC_KqOCZC0JITVr9-dj4q3qV0nxVU8PZtcURJQ0hViePi79KjrdsGdBU2anAe0LW1_fQHuYSuQEdQCQxyHv0Yo1PjNKBgURfGO7SIaj2AH9HZd3FBz5HyBi2mvi9X4Ne5fvbrck5oc45uo_JpDd5p9DVMCfJqoE870M3kR5fVwZ_mcS7tpr0v3ljVJ_jwuJ8UPxfXt_ObcvXty3J-uSo1p_VYWkLqBpigVnS2A267mlOeXWlazTg2zChQVBgKulVCC9WxlnOqic6GcGvYSbE8cE1Q93IT3aDigwzKyf1FiGup4uh0D5LX1GBKQUCtK1LVXcubBrRoW0IZNiSzPh9Ym6kbwOhsS1T9C-jLind3ch22khHWtlWVAaePgBh-T5BGObikoe-Vh-yZbBqCG55_m5X4oNQxpBTBPk0hWO5CIfehkLtQyH0ocsun5697avifAvYPz7izUQ</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Callahan, Joshua W</creator><creator>Abercrombie, Elizabeth D</creator><general>Frontiers Research Foundation</general><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20110101</creationdate><title>In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease</title><author>Callahan, Joshua W ; Abercrombie, Elizabeth D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-f1178e362f6bfbe5fb752533889c350d3daea26d2ec9a6c6ab39552c1c5135fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Basal Ganglia</topic><topic>Microdialysis</topic><topic>Neostriatum</topic><topic>neurodegeneration</topic><topic>Neuroscience</topic><topic>Substantia Nigra</topic><topic>transgenic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Callahan, Joshua W</creatorcontrib><creatorcontrib>Abercrombie, Elizabeth D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in systems neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Callahan, Joshua W</au><au>Abercrombie, Elizabeth D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease</atitle><jtitle>Frontiers in systems neuroscience</jtitle><addtitle>Front Syst Neurosci</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>5</volume><spage>61</spage><epage>61</epage><pages>61-61</pages><issn>1662-5137</issn><eissn>1662-5137</eissn><abstract>Huntington's disease (HD) is characterized by numerous alterations within the corticostriatal circuitry. The striatum is innervated by a dense array of dopaminergic (DA) terminals and these DA synapses are critical to the proper execution of motor functions. As motor disturbances are prevalent in HD we examined DA neurotransmission in the striatum in transgenic (tg) murine models of HD. We used in vivo microdialysis to compare extracellular concentrations of striatal DA in both a fragment (R6/2) model, which displays a rapid and severe phenotype, and a full-length (YAC128) model that expresses a more progressive phenotype. Extracellular striatal DA concentrations were significantly reduced in R6/2 mice and decreased concomitantly with age-dependent increasing motor impairments on the rotarod task (7, 9, and 11 weeks). In a sample of 11-week-old R6/2 mice, we also measured tissue concentrations of striatal DA and found that total levels of DA were significantly depleted. However, the loss of total DA content (&lt;50%) was insufficient to account for the full extent of DA depletion in the extracellular fluid (ECF; ∼75%). We also observed a significant reduction in extracellular DA concentrations in the striatum of 7-month-old YAC128 mice. In a separate set of experiments, we applied d-amphetamine (AMPH; 10 μm) locally into the striatum to stimulate the release of intracellular DA into the ECF. The AMPH-induced increase in extracellular DA levels was significantly blunted in 9-week-old R6/2 mice. There also was a decrease in AMPH-stimulated DA efflux in 7-month-old YAC128 mice in comparison to WT controls, although the effect was milder. In the same cohort of 7-month-old YAC128 mice we observed a significant reduction in the total locomotor activity in response to systemic AMPH (2 mg/kg). Our data demonstrate that extracellular DA release is attenuated in both a fragment and full-length tg mouse model of HD and support the concept of DA involvement in aspects of the syndrome.</abstract><cop>Switzerland</cop><pub>Frontiers Research Foundation</pub><pmid>21811446</pmid><doi>10.3389/fnsys.2011.00061</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1662-5137
ispartof Frontiers in systems neuroscience, 2011-01, Vol.5, p.61-61
issn 1662-5137
1662-5137
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_572d022e6e7c4147b9588ec6991230d1
source PubMed Central
subjects Basal Ganglia
Microdialysis
Neostriatum
neurodegeneration
Neuroscience
Substantia Nigra
transgenic
title In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A33%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20Dopamine%20Efflux%20is%20Decreased%20in%20Striatum%20of%20both%20Fragment%20(R6/2)%20and%20Full-Length%20(YAC128)%20Transgenic%20Mouse%20Models%20of%20Huntington's%20Disease&rft.jtitle=Frontiers%20in%20systems%20neuroscience&rft.au=Callahan,%20Joshua%20W&rft.date=2011-01-01&rft.volume=5&rft.spage=61&rft.epage=61&rft.pages=61-61&rft.issn=1662-5137&rft.eissn=1662-5137&rft_id=info:doi/10.3389/fnsys.2011.00061&rft_dat=%3Cproquest_doaj_%3E881085362%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c527t-f1178e362f6bfbe5fb752533889c350d3daea26d2ec9a6c6ab39552c1c5135fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=881085362&rft_id=info:pmid/21811446&rfr_iscdi=true